Article Archives

FDA Approves Triple Combination IDP-126 (Cabtreo™) for Acne

Bausch Health has announced that the U.S. Food and Drug Administration (FDA) has approved IDP-126 (Cabtreo™) for the treatment of acne in patients aged 12 years and older. IDP-126 (clindamycin

FDA Approves Bimekizumab for Moderate-to-Severe Plaque Psoriasis

The U.S. Food and Drug Administration (FDA) has approved BIMZELX® (bimekizumab-bkzx) for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is

AbbVie Announces Upadacitinib Meets Primary Endpoint of Phase 2 Trial for Vitiligo – Advances to Phase 3

AbbVie recently announced that its phase 2b study evaluating upadacitinib (RINVOQ®) for the treatment of adults with nonsegmental vitiligo (NSV) met the primary endpoint of percent change from baseline in

FDA Approves Arcutis’ Roflumilast Cream 0.3% for Plaque Psoriasis in Children Aged 6 to 11 Years

Arcutis Biotherapeutics recently announced that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) for the expanded indication of ZORYVE (roflumilast) cream 0.3% for the

Study Reports Colloidal Oatmeal Effective at Improving Atopic Dermatitis in Black Children

Kenvue recently revealed that an over-the-counter (OTC) moisturizer containing 1% colloidal oatmeal was shown to be effective in improving Eczema Area and Severity Index (EASI) scores in Black children. Colloidal

Hidradenitis Suppurativa May Involve Local Changes in the Skin

In a recent study, researchers aimed to characterize somatosensory profiles in patients with hidradenitis suppurativa (HS) at clinically affected and nonaffected areas compared with pain-free reference data. They noted that

Arcutis Announces Positive Long-Term Results of Roflumilast Cream 0.15%

Arcutis Biotherapeutics recently announced the interim results of its phase 3, long-term extension trial of roflumilast cream 0.15% for the treatment of atopic dermatitis (AD) in adults and children 6

Optimizing Acne Treatment Using Ceramide-Containing Skincare

Early in 2023, a group of nine dermatologists met to review and discuss the current literature on acne to understand both the socioeconomic and psychological effects of this skin condition

Study Evaluates Effects of Age and Sex on Alopecia Areata Comorbidities

Researchers sought to clarify the association between age and sex with various comorbidities in patients with alopecia areata.

Meet Karan Lal, DO, MS, Featured Speaker at SBS: West Coast Derm

Karan Lal, DO, MS, is a double-board-certified dermatologist who specializes in adult, pediatric, and cosmetic dermatology. His impressive educational background serves as a demonstration of his long-time interest and dedication

Study Shows Supplement Containing Amino Acid May Improve Efficacy of Hair Loss Treatments

Study evaluates efficacy of oral supplement containing hydrolyzed collagen and amino acids with drug treatments in patients with hair loss.

Launch of New Hair Regrowth Serum with Exosomes

ExoCel Bio™ has announced the launch of Refine, their new Exovex™ serum with a 75 billion concentration of exosomes, designed for hair regrowth. This high concentration of non-lyophilized, purified exosomes

Study Shows Dupilumab Successful in Treating Bullous Pemphigoid

A recent retrospective cohort study revealed that dupilumab was successful in treating bullous pemphigoid (BP). The study, which was conducted from Jan. 1, 2021, to Jul. 31, 2022, included 146

Ava T. Shamban, MD at SBS: West Coast Derm

Ava T. Shamban, MD, is a board-certified dermatologist with over 20 years of experience in the field. A scientist, researcher, and business owner, Dr. Shamban’s goal is to help her

Risankizumab Demonstrates Superior Efficacy in Treating Plaque Psoriasis as Compared to Apremilast in Phase 4 Study

In a recent study published in the British Journal of Dermatology, it was found that for patients with moderate psoriasis, treatment with risankizumab demonstrated superior efficacy compared to apremilast. AbbVie’s

Study Shows Combining Glycyrrhizin Tablets with 308 nm Excimer Laser Effective in Treating Vitiligo

During a recent systematic review, researchers determined that compound glycyrrhizin tablets combined with the 308 nm excimer laser proved more effective in treating vitiligo than using the laser alone. The

Retinol-Containing Neck Cream Improves Signs of Aging

Study reveals that retinol-containing topical neck cream significantly improved signs of aging by reducing lines, wrinkles, and crepiness.

Topical Therapeutic Demonstrates Significant Improvement in Atopic Dermatitis

Alphyn Biologics recently announced results from the first cohort of its Phase 2a clinical trial of AB-101a in treating atopic dermatitis.

Almirall Reveals Data From Tildrakizumab Study Demonstrates Significant Improvement in Wellbeing for Patients with Plaque Psoriasis

Almirall’s study shows tildrakizumab (Ilumetri®) significantly improved the wellbeing of patients with moderate-to-severe plaque psoriasis.

FDA Approves Verrica Pharmaceuticals Cantharidin for the Treatment of Molluscum Contagiosum

The FDA has approved cantharidin (YCANTH™) for the treatment of molluscum contagiosum in pediatric and adult patients.

LivDerm Articles

Latest Articles

Explore Articles